AnalystsWilliam PickeringWilliam Pickering's Stock Forecasts
AnalystsWilliam Pickering
Sectors:
Industries:
Analyst Ranking
Top 47%
#2146 out of 4563 analysts
Average Return
+0.86%
Win Rate
56%5 out of 9
Risk vs Reward
Poor
Good
William Pickering's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Vertex Pharmaceuticals IncVRTX | +36.16% | $302.66 | $412.11 | 2023-03-21 - 2024-03-20 | Buy |
Vertex Pharmaceuticals IncVRTX | +15.71% | $346.36 | $400.76 | 2023-05-03 - 2024-04-24 | Buy |
Vertex Pharmaceuticals IncVRTX | +13.19% | $354.05 | $400.76 | 2023-07-28 - 2024-04-24 | Buy |
Vertex Pharmaceuticals IncVRTX | +11.82% | $358.40 | $400.76 | 2023-08-02 - 2024-04-24 | Buy |
Biomarin Pharmaceutical IncBMRN | +10.03% | $92.08 | $82.84 | 2023-03-21 - 2023-10-23 | Sell |
William Pickering Analyst Color
Get additional color on William Pickering's coverage of popular stocks
William Pickering's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $1,125.00 | +24.10% | Initiates Coverage On | a month ago |
Biomarin Pharmaceutical IncBMRN | 2 | Hold | $82.00 | -10.09% | Upgrades | 6 months ago |
Vertex Pharmaceuticals IncVRTX | 4 | Buy | $390.00 | -2.68% | Maintains | 9 months ago |
Alnylam Pharmaceuticals IncALNY | 1 | Buy | $243.00 | N/A | Initiates Coverage On | a year ago |
Intellia Therapeutics IncNTLA | 1 | Buy | $54.00 | N/A | Initiates Coverage On | a year ago |
Beam Therapeutics IncBEAM | 1 | Hold | $37.00 | N/A | Initiates Coverage On | a year ago |
Allogene Therapeutics IncALLO | 1 | Hold | $6.00 | N/A | Initiates Coverage On | a year ago |
Crispr Therapeutics AgCRSP | 1 | Hold | $44.00 | N/A | Initiates Coverage On | a year ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Hold | $27.00 | N/A | Initiates Coverage On | a year ago |
Ionis Pharmaceuticals IncIONS | 1 | Sell | $31.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.